KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Net Margin (2016 - 2025)

Historic Net Margin for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to 7.86%.

  • Fulgent Genetics' Net Margin rose 125600.0% to 7.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.62%, marking a year-over-year increase of 457700.0%. This contributed to the annual value of 15.07% for FY2024, which is 429600.0% up from last year.
  • Per Fulgent Genetics' latest filing, its Net Margin stood at 7.86% for Q3 2025, which was up 125600.0% from 23.17% recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Net Margin registered a high of 55.84% during Q1 2021, and its lowest value of 181.76% during Q4 2023.
  • Over the past 5 years, Fulgent Genetics' median Net Margin value was 12.26% (recorded in 2024), while the average stood at 6.44%.
  • As far as peak fluctuations go, Fulgent Genetics' Net Margin plummeted by -1462000bps in 2023, and later surged by 1740300bps in 2024.
  • Fulgent Genetics' Net Margin (Quarter) stood at 41.2% in 2021, then tumbled by -186bps to 35.56% in 2022, then tumbled by -411bps to 181.76% in 2023, then soared by 96bps to 7.73% in 2024, then decreased by -2bps to 7.86% in 2025.
  • Its Net Margin was 7.86% in Q3 2025, compared to 23.17% in Q2 2025 and 15.69% in Q1 2025.